Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Monoclonal Anti-cd303 on the Inhibition of Type I Interferon Secretion in the Peripheral Blood of Patients With Autoimmune Diseases

NCT03370627 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT03370627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03370627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Monoclonal Anti-cd303 on the Inhibition of Type I Interferon Secretion in the Peripheral Blood of Patients With Autoimmune Diseases
Lead sponsor
University Hospital, Lille
Phase
Not applicable
Overall status
Completed
Start date
December 20, 2017
Completion date
May 25, 2019
Enrollment
138 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune disease